We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR Enhances Cancer Immunotherapy Helping Protect T-Cells Against Friendly Fire

News   Mar 07, 2018 | Original story from Washington University School of Medicine in St. Louis

 
CRISPR Enhances Cancer Immunotherapy Helping Protect T-Cells Against Friendly Fire

Scientists at Washington University School of Medicine in St. Louis now have used the gene-editing technology CRISPR to engineer human T cells that can attack human T cell cancers. They also engineered the T cells to eliminate a potentially dangerous side effect called graft-versus-host disease, where the therapeutic T cells that kill the cancer also attack the patient's organs. John DiPersio, MD, PhD, (right) leads a team developing an "off-the-shelf" CAR-T immunotherapy for hard-to-treat T cell cancers. A new study evaluates the approach in mice with human T cell acute lymphoblastic leukemia. Shown is DiPersio working with co-author Armin Ghobadi, MD, in the lab. Credit: Huy Mach

 
 
 

RELATED ARTICLES

Boy With Rare Brain Tumor One of First in UK to Receive Proton Beam Therapy Treatment

News

A 15-year old from West Sussex, diagnosed with a brain tumor last August, will become one of the first patients in the UK to receive state-of-the-art proton beam therapy treatment at a new £125 million center opened in Manchester.

READ MORE

Immune System Protein Helps Suppress HIV

News

A new study reveals the role of a protein that serves to block HIV gene expression once it has entered human cells.

READ MORE

Probiotic Consumption Impacts Breast Milk Composition

News

The complex sugars found in human breastmilk, long believed to be fixed in their composition, may change in women who are taking probiotics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE